Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. ETF
  3. ADMA
ADMA logo

ADMA

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

ADMA News

ADMA Biologics Announces $200 Million Capital Return Initiative

Mar 02 2026seekingalpha

ADMA Biologics (ADMA) Q4 2025 Earnings Transcript

Feb 28 2026NASDAQ.COM

ADMA Biologics Reports Strong 2025 Financial Results

Feb 28 2026Yahoo Finance

ADMA Biologics Reports Strong Q4 2025 Earnings and Positive Outlook

Feb 26 2026seekingalpha

ADMA Biologics to Announce Q4 Earnings on February 25

Feb 24 2026seekingalpha

Ranger Investment Management Increases Solaris Holdings

Feb 14 2026Fool

Ranger Investment Management Increases Solaris Shares

Feb 14 2026NASDAQ.COM

ADMA Biologics CEO to Present at J.P. Morgan Healthcare Conference

Jan 05 2026Globenewswire

Stonepine Capital Fully Exits ANI Pharmaceuticals, Reporting $2.52 Million Loss

Dec 28 2025Yahoo Finance

Eight Stock Selections to Capitalize on a Robust Sector of the Market

Dec 11 2025MarketWatch

Wall Street Analysts Predict a 60.24% Surge for Adma Biologics (ADMA): Important Insights Before You Invest

Nov 27 2025NASDAQ.COM

Adma Biologics (ADMA) Receives Upgrade to Buy: Key Information You Need to Know

Nov 25 2025NASDAQ.COM

ADMA Surpasses Important Moving Average Threshold

Nov 24 2025NASDAQ.COM

Kodiak Reports Larger-than-Expected Loss in Q3, Emphasizes Pipeline Development

Nov 14 2025NASDAQ.COM

Significant Options Trading on Wednesday: ADMA, RXO, DOCN

Nov 05 2025NASDAQ.COM

Reasons Behind Adma Biologics (ADMA) Decline Exceeding Market Trends

Oct 16 2025NASDAQ.COM